Stock Taper
SCREENER COMPARE ANY 2 STOCKS
WHWK
WHITEHAWK THERAPEUTICS INC
NASDAQ
$4.62
▼ DOWN 5.13% (-0.25)

KEY STATISTICS

Market Cap$263.38 M
52w High$5.50
52w Low$1.76
Dividend Yield—
Frequency—
P/E-4.12
Volume96.99K
Shares Out.57.01M

COMPANY

LEADERSHIP

David J. Lennon
CHIEF EXECUTIVE
David J. Lennon

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 1, 2017
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
32

PRICE TARGET

Target High$9.00
Target Low$7.00
Target Median$8.00
Target Consensus$8.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.—
NOV
5
THU

SPLIT RECORD

DATETYPERATIO
2021-08-27Forward15:1

PRICE

$4.62 ▼ DOWN 5.13% (−$0.25)
OVERLAYS
$4.60$4.70$4.80$4.909:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.62

About Whitehawk Therapeutics Inc

https://ir.whitehawktx.com ↗

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

INDUSTRY

Biotechnology

A PRODUCT WHITEHAWK THERAPEUTICS INC IS KNOWN FOR

HWK-007
HWK-007

HWK-007 is Whitehawk Therapeutics' leading ADC targeting PTK7, overexpressed in cancers, with FDA IND clearance and a Phase 1 trial underway for lung, ovarian, and endometrial cancers.

COMPETITORS

COMPETITOR
ADCT COMPARE
KA KALV COMPARE
PYXS COMPARE
STRO COMPARE

Revenue by Products

IconPRODUCTFY2025
Product$7.14M

ETFS HOLDING THIS STOCK

ETFS HOLDING
45
LISTED HERE
9
RANKED BY POSITION SIZE
VTI
0.00% · 888.0K
IWM
0.00% · 724.6K
AVSC
0.01% · 62.7K
GSSC
0.02% · 51.7K
XRSG.L
0.00% · 29.7K
QQQS
0.50% · 23.7K
RSSL
0.01% · 15.4K
DFAU
0.00% · 3.6K
URTY
0.00% · 1.3K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score1

INSIDER TRADES

★
DIRECTOR
Dalal Anupam
Purchase · 1.3M shares
2026-05-14
★
DIRECTOR
Dalal Anupam
Purchase · 38.0K shares
2026-06-12
★
DIRECTOR, 10 PERCENT OWNER, OTHER: SEE REMARKS
Aghazadeh Behzad
Purchase · 38.0K shares
2026-06-12
★
DIRECTOR
Reeve Emma
Purchase · 38.0K shares
2026-06-12

SECTORS PEERS

PEERPRICE
IMMX$13.94COMPARE
OVID$2.80COMPARE
ZNTL$3.80COMPARE
MGNX$4.13COMPARE
ONCY$0.86COMPARE
PLRX$1.11COMPARE
CLNN$4.23COMPARE
CNTX$0.38COMPARE